3.01 USD
-0.06
1.95%
At close Updated Dec 12, 4:00 PM EST
1 day
-1.95%
5 days
-5.35%
1 month
-4.14%
3 months
-13.26%
6 months
-32.21%
Year to date
-29.51%
1 year
-34.85%
5 years
-86.32%
10 years
-86.32%
 

About: Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Employees: 4,766

0
Funds holding %
of 7,507 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™